Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 44, 2012, Pages 18120-18125

  Anderson, Garret R ^a   Galfin, Timothy ^a   Xu, Wei ^a   Aoto, Jason ^a   Malenka, Robert C ^a   Südhof, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendrite; Synaptogenesis

Indexed keywords

CELL ADHESION MOLECULE; PROTEIN CASPR1; PROTEIN CASPR2; PROTEIN CASPR3; PROTEIN SEZ6; PROTEIN SEZ6L; PROTEIN SEZ6L2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTISM; BRAIN CORTEX; BRAIN NERVE CELL; CELL ADHESION; CONTROLLED STUDY; DENDRITIC CELL; GENE IDENTIFICATION; GENETIC SCREENING; GENOME ANALYSIS; MOUSE; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNAPTIC TRANSMISSION;

AUTISTIC DISORDER; DENDRITIC CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; NERVE NET; NERVE TISSUE PROTEINS; RNA INTERFERENCE;

EID: 84868121906     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216398109     Document Type: Article

References (45)

1. Holt R, Monaco AP (2011) Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Mol Med 3(8):438-450.
2. State MW, Levitt P (2011) The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 14(12):1499-1506.
3. Persico AM, Bourgeron T (2006) Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends Neurosci 29(7):349-358.
4. Peñagarikano O, Geschwind DH (2012) What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 18(3):156-163
5. Friedman JI, et al. (2008) CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13(3):261-266.
6. Mefford HC, et al. (2010) Genome-wide copy number variation in epilepsy: Novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 6(5):e1000962.
7. Strauss KA, et al. (2006) Recessive symptomatic focal epilepsy and mutant contactinassociated protein-like 2. N Engl J Med 354(13):1370-1377.
8. Belloso JM, et al. (2007) Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur J Hum Genet 15(6): 711-713.
9. Verkerk AJ, et al.; Tourette Syndrome Association International Consortium for Genetics (2003) CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82(1):1-9.
10. O'Dushlaine C, et al. (2011) Molecular pathways involved in neuronal cell-adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16(3):286-292.
11. Elia J, et al. (2010) Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15(6):637-646.
12. Zweier C, et al. (2009) CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt- Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 85(5):655-666.
13. Sehested LT, et al. (2010) Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features. Am J Med Genet A 152A(12):3115-3119.
14. Vernes SC, et al. (2008) A functional genetic link between distinct developmental language disorders. N Engl J Med 359(22):2337-2345.
15. Newbury DF, Monaco AP (2010) Genetic advances in the study of speech and language disorders. Neuron 68(2):309-320.
16. Petrin AL, et al. (2010) Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case. Am J Med Genet A 152A(12): 3164-3172.
17. Tan GC, Doke TF, Ashburner J, Wood NW, Frackowiak RS (2010) Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2. Neuroimage 53(3):1030-1042.
18. Scott-Van Zeeland AA, et al. (2010) Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2(56):56ra80.
19. Poliak S, et al. (1999) Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24(4):1037-1047.
20. Südhof TC (2008) Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455(7215):903-911.
21. Sanders SJ, et al. (2011) Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70(5):863-885.
22. Kim HG, et al. (2008) Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82(1):199-207.
23. Levy D, et al. (2011) Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70(5):886-897.
24. Peles E, Salzer JL (2000) Molecular domains of myelinated axons. Curr Opin Neurobiol 10(5):558-565.
25. Girault JA, Oguievetskaia K, Carnaud M, Denisenko-Nehrbass N, Goutebroze L (2003) Transmembrane scaffolding proteins in the formation and stability of nodes of Ranvier. Biol Cell 95(7):447-452.
26. Peñagarikano O, et al. (2011) Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147(1):235-246.
27. Poliak S, et al. (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162(6):1149-1160.
28. Xu W, et al. (2012) Distinct neuronal coding schemes in memory revealed by selective erasure of fast synchronous synaptic transmission. Neuron 73(5):990-1001.
29. Kaeser PS, et al. (2011) RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 144(2):282-295.
30. Geppert M, et al. (1994) Synaptotagmin I: A major Ca2+ sensor for transmitter release at a central synapse. Cell 79(4):717-727.
31. Gunnersen JM, et al. (2007) Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons. Neuron 56(4):621-639.
32. Alvarez VA, Ridenour DA, Sabatini BL (2006) Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J Neurosci 26(30):7820-7825.
33. Peles E, et al. (1997) Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 16(5):978-988.
34. Einheber S, et al. (1997) The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139(6):1495-1506.
35. Menegoz M, et al. (1997) Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 19(2):319-331.
36. Traka M, et al. (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162(6): 1161-1172.
37. Inda MC, DeFelipe J, Muñoz A (2006) Voltage-gated ion channels in the axon initial segment of human cortical pyramidal cells and their relationship with chandelier cells. Proc Natl Acad Sci USA 103(8):2920-2925.
38. Horresh I, Bar V, Kissil JL, Peles E (2010) Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. J Neurosci 30(7): 2480-2489.
39. Horresh I, et al. (2008) Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons. J Neurosci 28(52):14213-14222.
40. Charles P, et al. (2002) Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Curr Biol 12(3):217-220.
41. Stork T, et al. (2009) Drosophila Neurexin IV stabilizes neuron-glia interactions at the CNS midline by binding to Wrapper. Development 136(8):1251-1261.
42. Banerjee S, et al. (2010) Drosophila neurexin IV interacts with Roundabout and is required for repulsive midline axon guidance. J Neurosci 30(16):5653-5667.
43. Peles E, et al. (1995) The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82(2):251-260.
44. Milev P, Maurel P, Häring M, Margolis RK, Margolis RU (1996) TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein- tyrosine phosphatase-zeta/beta, and N-CAM. J Biol Chem 271(26):15716-15723.
45. Zeng L, D'Alessandri L, Kalousek MB, Vaughan L, Pallen CJ (1999) Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J Cell Biol 147(4):707-714.